June 5, 2023

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets Lotus Pharmaceuticals will acquire worldwide rights for NRX-101 for S-TRBD and will be responsible for commercialization of NRX-101 in markets outside the US through Lotus’s

Continue Reading

Fuel prices expected to decrease

Cash strapped consumers will experience some relief at the pumps this week when the price of all grades of petrol and diesel decreases.The price of paraffin will also decrease, with an increase in the price of gas.Fuel price adjustments as announced by…

Continue Reading

Recent Posts